Skip to main content
Margaret Von-Mehren, MD, Oncology, Philadelphia, PA, Temple University Hospital

MargaretVon-MehrenMD

Oncology Philadelphia, PA

Hematologic Oncology, Sarcoma

Fox Chase Cancer Center

Dr. Von-Mehren is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Von-Mehren's full profile

Already have an account?

  • Office

    333 Cottman Ave
    Fox Chase Cancer Center
    Philadelphia, PA 19111
    Phone+1 215-728-6900
    Fax+1 215-214-1425
  • Is this information wrong?

Summary

  • Dr. Margaret von Mehren is an oncologist in Philadelphia, PA at Fox Chase Cancer Center in the Temple University Health System. She received her medical degree from Albany Medical College and has been in practice 28 years. She specializes in management of sarcoma with a special emphasis on Gastrointestinal Stromal Tumors.

Education & Training

  • Temple University Hospital
    Temple University HospitalFellowship, Hematology and Medical Oncology, 1993 - 1996
  • NYU Grossman School of Medicine
    NYU Grossman School of MedicineResidency, Internal Medicine, 1989 - 1992
  • Albany Medical College
    Albany Medical CollegeClass of 1989

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 2021 - 2025
  • PA State Medical License
    PA State Medical License 1992 - 2024
  • NY State Medical License
    NY State Medical License 1990 - 1992
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • A retrospective natural history study of patients (pts) with PDGFR± D842V mutant advanced gastrointestinal stromal tumor (GIST) previously treated with a tyrosine kina... 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018

Hospital Affiliations